Metabolic Medical Institute (MMI) to Host Healthy Aging Therapeutics Symposium at Harvard Medical School, September 20-21, 2014

Boca Raton, FL, April 21, 2014 --(PR.com)-- Over 300 healthcare practitioners from all specialties, both international and domestic, will convene at Harvard Medical School’s Joseph B. Martin Conference Center September 20-21, 2014 for the Healthy Aging Therapeutics Symposium. This symposium will feature some of the most knowledgeable and respected experts in the area of healthy aging that will discuss the most relevant and pertinent topics in the rapidly changing healthcare industry. These leading experts come to the stage from both the medical and biotech worlds with years of experience.

Select topics will include pharmaceutical approaches to treating diseases of aging; dyslipidemic-induced vascular disease; oxidative stress; telomerase; and much more.

Featured Speakers include:
· Christoph Westphal, MD, PhD is on the Board of Fellows of Harvard Medical School, founder and partner of Longwood Fund, co-founder and executive chairman of Verastem as well as co-founder of Sirtris. Dr. Westphal has spearheaded many research projects engineering experimental medicine for several incurable cancers and serious inflammatory disorders.
· Leonard Pershing Guarente, PhD is co-chair of the Scientific Advisory Board at Sirtris Pharmaceuticals, Inc., is the Novartis Professor of Biology at MIT, and serves on the Advisory Board of Segterra Inc.
· David Sinclair, PhD is a Professor of Genetics at Harvard Medical School, Co-Director of the Paul F. Glenn Laboratories for the Molecular Biology of Aging, Associate Member of the Broad Institute for Systems Biology, and co-founder of Sirtris Pharmaceuticals.
· Mark Houston, MD, MS, ABAARM, FACP, FAHA is Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine, Director of the Hypertension Institute and Vascular Biology in Nashville, TN, and Medical Director of the Division of Human Nutrition at Saint Thomas Hospital. Dr. Houston also runs an active clinic in Nashville, is involved in clinical research, teaches, and is well published on the topics of Hypertension and Vascular Biology.
· Mark Rosenberg, MD is an integrative cancer specialist and research scientist that has been involved with drug research since 1991. He is actively involved in the development of drugs and techniques to combat cancer, obesity and age-related diseases. Dr. Rosenberg has an active clinic in which he practices daily treating both healthy aging and integrative cancer therapies.
· Michael Schmidt, PhD is co-chair of the Advanced Pattern Analysis and Countermeasures Group. He is Course Director of the Clinical Genomics, Proteomics, & Metabolomics program, Integrative Metabolic Medicine Program, at George Washington University. Dr. Schmidt’s work is focused on assessment, clinical therapeutics, and countermeasures associated with converging variables within molecular networks.
· David Perlmutter, MD is a Board Certified neurologist and Fellow of the American College of Nutrition. He is a frequent lecturer at symposia sponsored by prestigious medical institutions such as Columbia University, Scripps Institute, and Harvard University.

For more information on this uniquely innovative medical education event, please call MMI at 866.846.1107 or visit www.mmimedicine.com.

Metabolic Medical Institute, Inc. (MMI) is a medical organization dedicated to promoting health and prevention of disease by educating health professionals, researchers and the public. MMI provides educational courses through conferences, workshops, online modules, and Fellowships and Certification programs.

MMI educational courses are affiliated with leading universities and taught by Nobel-prize winning scientists, expert clinicians and researchers drawn from a variety of medical, basic science, technology and business disciplines. MMI programs are held to the highest standards of academic rigor and train practitioners in the methods of Integrative and Metabolic Medicine, an approach that uncovers the deeper causes of disease and reveals the uniqueness of each patient. The goal is to create a complete health care provider, with competencies in systems biology, the use of technology and advanced detection methods of disease, and research skills to collect data in clinical settings.